Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Gland Pharma Ltd. ( (IN:GLAND) ) just unveiled an announcement.
Gland Pharma Limited has announced a change in the contact details of its Registrar and Share Transfer Agent (RTA) due to a rebranding from ‘Link Intime India Private Limited’ to ‘MUFG Intime India Private Limited’. This update is crucial for shareholders and stakeholders who need to interact with the RTA for queries or service requests, ensuring continued smooth operations and communication.
More about Gland Pharma Ltd.
Gland Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of complex injectables. The company is known for its wide range of products that cater to various therapeutic areas, serving both domestic and international markets.
YTD Price Performance: -18.25%
Average Trading Volume: 14,139
Current Market Cap: 238.9B INR
See more insights into GLAND stock on TipRanks’ Stock Analysis page.